Direct conversion from oral morphine to transdermal fentanyl: A multicenter study in patients with cancer pain

Pain

Volumn 64, Issue 3, 1996, Pages 527-534

  Donner, Barbara ^a   Zenz, Michael ^a   Tryba, Michael ^a   Strumpf, Michael ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Cancer pain; Fentanyl; Morphine; Oral; Sustained release; Transdermal

Indexed keywords

FENTANYL; MORPHINE;

ADULT; AGED; ANALGESIA; ARTICLE; CANCER PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HUMAN; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TRANSDERMAL DRUG ADMINISTRATION; WITHDRAWAL SYNDROME;

EID: 0030014612     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3959(95)00180-8     Document Type: Article

References (49)

1. Calis, K.A., Kohler, D.R. and Corso, D.M., Transdermally administered fentanyl for pain management, Clin. Pharmacol., 11 (1992) 22-36.
2. Caplan, R.A. and Southam, M., Transdermal fentanyl: an overview of clinical progress. In: F.G. Estafanous (Ed.), Opioids in Anesthesia, Butterworth-Heinemann, 1991, pp. 267-273.
3. Donner, B., Zenz, M., Tryba, M. and Strumpf, M., Transdermales Fentanyl in der Tumorschmerztherapie, Der Schmerz, 7 (1993a) 18-24.
4. Donner, B., Zenz, M., Tryba, M. and Kurz-Müller, K., Fentanyl TTS zur postoperativen Schmerztherapie, Anaesthesist, 42 (1993b) 309-315.
5. Enck, R.E., Transdermal narcotics for pain control, Am. J. Hosp. Pall. Care, 7/8 (1990) 15-17.
6. Foley, K.M., The treatment of cancer pain, New Engl. J. Med., 313 (1985) 84-95.
7. Freye, E., Opioide in der Medizin, Springer, Heidelberg, 1991.
8. Gourlay, G.K., Kowalski, S.R., Plummer, J.L., Cherry, D.A., Gaukroger, P. and Cousins, M.J., The transdermal administration of fentanyl in the treatment of postoperative pain: pharmacokinetics and pharmacodynamic effects, Pain, 37 (1989) 193-202.
9. Gupta, S.K., Southam, M., Gale, R. and Hwang, S.S., System functionality and physicochemical model of fentanyl transdermal system, J. Pain Sympt. Manag., 7 (Suppl.) (1992) 17-26.
10. Herbst, L.H. and Strause, L.G., Transdermal fentanyl use in hospice home-care patients with chronic cancer pain, J. Pain Sympt. Manag., 7 (Suppl.) (1992) 54-57.
11. Holley, F.O. and van Stevens, C., Postoperative analgesia with fentanyl: pharmacokinetics and pharmacodynamics of constant-rate i.v. and transdermal delivery, Br. J. Anaesth., 60 (1988) 608-613.
12. Jage, J., Portenoy, R.K. and Foley, M.K., Die Bestimmung des i.m. Morphin-Äquivalents zur Therapie des Krebsschmerzes mit verschiedenen Opioiden oder bei Wechsel des Verabreichungsweges, Schmerz, 4 (1990) 110-117.
13. Janssen Pharmaceutica Inc., Duragesic, Product Infomation, Piscataway, NJ, 1990.
14. Janssen Phamaceutica Inc., Product Monograph 'Duragesic', fentanyl transdermal system, Mississauga, Ontario, 1991.
15. Jurna, I. and Baldauf, J., Retardiert freigesetztes Naloxon oral: Aufhebung der Obstipation durch orales Morphin ohne Beseitigung der Analgesie, Schmerz, 7 (1993) 314-321.
16. Korte, W. and Morant, R., Transdermal fentanyl in uncontrolled cancer pain: titration on day-to-day basis as a procedure for safe and effective dose finding. A pilot study in 20 patients, Support Care Cancer, 2 (1994) 123-127.
17. Larijani, G.E., Bell, S.D., Goldberg, M.E. and Lessin, J.B., Pharmacokinetics of fentanyl following transdermal application, Anesthesiology, 69 (1988) A363.
18. Latasch, L. and Lüders, S., Transdermal fentanyl against postoperative pain, Acta Anaesth. Belg., 40 (1989) 113-118.
19. Lehmann, K.A. and Zech, D., Transdermal Fentanyl, J. Pain Sympt. Manag., 7 (Suppl.) (1992) 8-16.
20. Lehr, V.T. and Renaud, E.A., High transdermal fentanyl requirements in a patient with chronic cancer pain, Ann. Pharmacother., 27 (1993) 575-578.
21. Levy, S., Jacobs, S., Johnson, J., Schultz, N., Kowal, C., Meisler, A., Lee, J. and Boggiu, K., Transdermal fentanyl: pain and quality-of-life effects, Proc. Am. Soc. Clin. Pharm., 7 (1988) 292.
22. Levy, M.H., Rosen, S.M. and Kedziera, P., Transdermal fentanyl: seeding trial in patients with chronic cancer pain, J. Pain Sympt. Manag., 7 (Suppl.) (1992) 48-50.
23. MacDonald, N., Commentary, J. Pain Sympt. Manag., 8 (1993) 320-321.
24. Mather, L.E., Clinical pharmacokinetics of fentanyl and its newer derivatives, Clin. Pharmacol., 8 (1983) 422-446.
25. Maves, T.J. and Barcellos, W.A., Management of cancer pain with transdermal fentanyl: phase IV trial, University of Iowa, J. Pain Sympt. Manag., 7 (Suppl.) (1992) 58-62.
26. Miser, A.W., Narang, P.K., Dothage, J.A., Young, R.C., Sindelar, S. and Miser, J.S., Transdermal fentanyl for pain control in patients with cancer, Pain, 37 (1989) 15.
27. Moser, K.H., Transdermal fentanyl in cancer pain, Am. Family Physician, 45 (1992) 2289-2294.
28. Patt, R.B. and Hogan, L.A., Transdermal fentanyl for chronic cancer pain: detailed case reports and the influence of confounding factors, J. Pain Sympt. Manag., 7 (Suppl.) (1992) 51-53.
29. Payne, R., Experience with transdermal fentanyl in advanced cancer pain, Eur. J. Pain, 11 (1990) 98-101.
30. Plezia, P.M., Kramer, T.H., Linford, J. and Hameroff, S.R., Transdermal fentanyl: pharmacokinetics and preliminary clinical evaluation, Pharmacotherapy, 9 (1989) 2-9.
31. Portenoy, R.K., Southam, M., Gupta, S.K., Lapin, J., Layman, M., Inturrisi, C.E. and Foley, K.M., Transdermal fentanyl for cancer pain. Repeated dose pharmocokinetics, Anesthesiology, 78 (1993) 36-43.
32. Rose, P.G., Macfee, M.S. and Boswell, M.V., Fentanyl transdermal system overdose secondary to cutaneous hyperthermia, Anesth. Analg., 77 (1993) 390-391.
33. Rowbotham, D.J., Wyld, R., Peacock, J.E. and Duthie, D.J.R., Transdermal fentanyl for the relief of pain after upper abdominal surgery, Br. J. Anaesth., 63 (1989) 56-59.
34. Roy, S.D. and Flynn., G.L., Transdermal delivery of narcotic analgesics: pH, anatomical and subject influences on cutaneous permeability of fentanyl and sufentanil, Pharmaceut. Res., 7 (1990) 842-847.
35. Sandler, A., Transdermal fentanyl: acute analgesic clinical studies, J. Pain Sympt. Manag., 7 (Suppl.) (1992) 27-35.
36. Simmonds, M.A., Payne, R., Richenbacher, J., Moran, K., Southam, M.A. and Hershe, M.S., TTS (fentanyl) in the management of pain in patients with cancer, Proc. Am. Soc. Clin. Oncol., 8 (1989) 324 Abstract.
37. Simmonds, M.A., Transdermal fentanyl therapy: clinical developement in the United States, Anti-Cancer Drugs, 6 (Suppl. 3) (1995) 35-38.
38. Skoyles, J., Tordoff, S., Rabey, P. and Rowbotham, D., Transdermal fentanyl administered in cancer pain, 7th World Congress on Pain, France (1993) 335 Abstract.
39. Slover, R., Transdermal fentanyl: clinical trial at the University of Colorado Health Science Center, J. Pain Sympt. Manag., 7 (Suppl.) (1992) 45-47.
40. Southam, M., Gupta, S., Knowels, M. and Hwang, S.S., Transdermal fentanyl: an overview of pharmacokinetics, efficacy and safety. In: K.A. Lehmann and D. Zech (Eds.), Transdermal Fentanyl, Springer, Heidelberg, 1991, pp. 107-116.
41. Van Bastelaere, M., Rolly, G. and van Peer, A., Pharmacokinetic behaviour of transdermal fentanyl, Br. J. Anaesth., 70 (Suppl. 1) (1993) 75 Abstract.
42. Van Deventer, P.L., Verbiest, H.B.C., Kansen, P.J., van den Bent, M.J. and Vecht, C.J., Transdermal fentanyl: a feasibility study in patients with chronic cancer pain, 7th World Congress on Pain, Paris, France, 330.
43. Van Gestel, S. and Amery, W., Postmarketing surveillance report of transdermal fentanyl (fentanyl TTS), Janssen Research Foundation, Berse, Belgium, 1992.
44. Varvel, J.R., Shafer, S.L., Hwang, S.S., Coen, P.A. and Stanski, D.R., Absorption characteristics of transdermally administered fentanyl, Anesthesiology, 70 (1989) 928-934.
45. Zech, D. and Lehmann K.A., Transdermal fentanyl in combination with initial intravenous dose titration by patient controlled analgesia, Anti-Cancer Drugs, 6 (Suppl. 3) (1995) 44-49.
46. Zech, D., Grond, S. and Lynch, J., Clinical Experience. In: K.A. Lehmann and D. Zech (Eds.), Transdermal Fentanyl, Springer, Heidelberg, 1991a, pp. 171-187.
47. Zech, D., Lehmann, K.A. and Rupperth, J., Current development of pain treatment I, Pain Clin., 4 (1991b) 177-181.
48. Zech, D., Grond, S., Lynch, J. and Lehmann, K.A., Transdermales Fentanyl zur Schmerztherapie bei Tumoren im GIT und der Kopf-Hals-Region, Schmerz, 5 (1991c) 181.
49. Zech, D., Grond, S., Dauer, H.G., Stollenwerk, B. and Lehmann, K.A., Transdermal fentanyl and initial dose-finding with patient-controlled analgesia in cancer pain, A pilot study with 20 terminally ill cancer patients, Pain, 50 (1992) 293-301.